Department of Experimental Medical Science, BMC D12, Lund University, SE-221 84 Lund, Sweden; Department of Urology, Qing Yuan City People's Hospital, Jinan University, Guang Dong, China.
Department of Experimental Medical Science, BMC D12, Lund University, SE-221 84 Lund, Sweden.
Eur J Pharmacol. 2015 Sep 5;762:82-8. doi: 10.1016/j.ejphar.2015.05.037. Epub 2015 May 21.
The aim of the present study was to investigate the expression and distribution of membrane receptors after bladder outlet obstruction (BOO). Partial bladder outlet obstruction (BOO) was induced in female rats and bladders were harvested after either 10 days or 6 weeks of BOO. The expression of different receptors was surveyed by microarrays and corroborated by immunohistochemistry and western blotting. A microarray experiment identified 10 membrane receptors that were differentially expressed compared to sham-operated rats including both upregulated and downregulated receptors. Four of these were selected for functional experiments on the basis of magnitude of change and relevance to bladder physiology. At 6 weeks of BOO, maximal contraction was reduced for neuromedin B and vasopressin (AVP), consistent with reductions of receptor mRNA levels. Glycine receptor-induced contraction on the other hand was increased and receptor mRNA expression was accordingly upregulated. Maximal relaxation by the β3-adrenergic receptor agonist CL316243 was reduced as was the receptor mRNA level. Immunohistochemistry supported reduced expression of neuromedin B receptors, V1a receptors and β3-adrenergic receptors, but glycine receptor expression appeared unchanged. Western blotting confirmed repression of V1a receptors and induction of glycine receptors in BOO. mRNA for vasopressin was detectable in the bladder, suggesting local AVP production. We conclude that changes in receptor expression following bladder outlet obstruction are non-uniform. Some receptors are upregulated, conferring increased responsiveness to agonist, whereas others are downregulated, leading to decreased agonist-induced responses. This study might help to select pharmacological agents that are effective in modulating lower urinary tract symptoms in BOO.
本研究旨在探讨膀胱出口梗阻(BOO)后膜受体的表达和分布。部分膀胱出口梗阻(BOO)诱导雌性大鼠,梗阻 10 天或 6 周后采集膀胱。通过微阵列调查不同受体的表达,并通过免疫组织化学和 Western blot 进行验证。微阵列实验鉴定了 10 种与 sham 手术大鼠相比差异表达的膜受体,包括上调和下调的受体。基于变化幅度和与膀胱生理学的相关性,选择其中 4 种进行功能实验。在 BOO 6 周时,神经降压素 B 和加压素(AVP)的最大收缩减少,与受体 mRNA 水平的降低一致。另一方面,甘氨酸受体诱导的收缩增加,相应地受体 mRNA 表达上调。β3-肾上腺素能受体激动剂 CL316243 引起的最大松弛减少,受体 mRNA 水平降低。免疫组织化学支持神经降压素 B 受体、V1a 受体和β3-肾上腺素能受体表达减少,但甘氨酸受体表达似乎不变。Western blot 证实 BOO 时 V1a 受体受抑制和甘氨酸受体诱导。膀胱中可检测到加压素 mRNA,提示局部产生 AVP。我们得出结论,膀胱出口梗阻后受体表达的变化是不均匀的。一些受体上调,赋予对激动剂更高的反应性,而另一些受体下调,导致激动剂诱导的反应性降低。本研究可能有助于选择有效调节 BOO 下尿路症状的药物。